logo

CRVO

CervoMed·NASDAQ
--
--(--)
--
--(--)
8.94 / 10
Outperform

Analyst consensus is overwhelmingly bullish: six Strong Buy ratings (100%). Fund‑flow score is 7.81 (good) with overall positive inflows, though medium and large investors show slight outflows. Sentiment rating is Outperform, suggesting strong capital support despite mixed historical analyst performance.

FundamentalSentiment(8.94)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-03-18
InstitutionRoth Capital
Times predicted2
Historical Win Rate50.0%
What is the market sentiment for CRVO?
  • CRVO holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.94/10 (Outperform).